EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu

Runtian Wang, Qin Hu, Yueyao Wu, Nan Guan, Xin Han, Xiaoxiang Guan

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023

DOI: 10.1016/j.bbcan.2023.188962 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023. Verfasst von Runtian Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reprogramming of the tumor microenvironment (TME) is a hallmark of cancer. Metabolic reprogramming is a vital approach to sustaining the energy supply in the TME. This alteration exists in both cancer cells and TME cells, collectively establishing an immunotolerant niche to facilitate tumor progression. Limited resources lead to metabolic competition and hinder the biological functions of anti-tumoral immunity. Reprogramming of lipid metabolism and tumor progression is closely related to each other. Due to the complexity of fatty acid (FA) types and the lack of an effective approach for detection, the mechanisms and effects of FA metabolic reprogramming have been unclear. Herein, we review FA metabolism in the tumor milieu, summarize how FA metabolic reprogramming influences antitumor immune response, suggest the mechanisms by which FAs affect immunotherapy against cancer, and discuss the potential of FA metabolism-based drugs in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismNeoplasmsHumansAnimalsTumor MicroenvironmentFatty AcidsTumor Escape

Stichwörter der Autor:innen

Fatty acidMetabolic reprogrammingMetastasisStatinTumorigenesiscancer progression

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109, USA.
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic addr…
  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalize…

Zitieren

APA

Wang, R., Hu, Q., Wu, Y., Guan, N., Han, X., & Guan, X. (2023). Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.188962

Vancouver

Wang R, Hu Q, Wu Y, Guan N, Han X, Guan X. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023. doi:10.1016/j.bbcan.2023.188962

BibTeX
@article{Wang2023,
  author = {Wang, Runtian and Hu, Qin and Wu, Yueyao and Guan, Nan and Han, Xin and Guan, Xiaoxiang},
  title = {Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2023},
  doi = {10.1016/j.bbcan.2023.188962}
}
Kostenlos starten →